MODERATOR
:
SPEAKER
(S):
Glenn Ramsey, MD, Professor of Pathology, Northwestern University
Post-Donation Information: Does it Contribute to Safety?,,
Mindy Goldman, MD, Medical Director, Canadian Blood Services
Post-Donation Information: Does It Contribute to Safety?
Dr. Anne Eder, MD, PhD, Executive Medical Officer, American Red Cross
Description
Each year, over 30,000 biological product deviation reports related to post-donation information are filed with the FDA by blood centers. In many instances, post-donation information leads to product withdrawal or recall, and generates questions about recipient risk and the need for recipient notification or additional testing. This session will provide an overview of the main causes of post-donation information in several countries. The blood center and hospital perspectives will be presented, with a focus on actual risk associated with involved components.
-
Assess recipient risks related to product withdrawals or recalls associated with post-donation information.
-
Compare decisions about recipient notification in your facility with your peers in other institutions.
-
Review the main reasons for information becoming available after donation.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.